A COMFORTABLE CHOICE

FOR YOU AND YOUR PATIENTS

The Argyle™ Safety Fistula Cannula with Anti-Reflux Valve offers a patient-preferred alternative to traditional steel needles.1 The design includes two parts—a temporary metal needle and soft cannula. The needle is used to guide the cannula into the arteriovenous fistula or graft (AVF or AVG) and is removed as the cannula is advanced, leaving only the flexible cannula in place for hemodialysis.

For Patients          For Clinicians

Product Features

Cannulation is one of the primary causes of arteriovenous fistula (AVF) complications4,5. The Argyle™ Safety Fistula Cannula offers an AVF/AVG access solution that is designed to reduce complications associated with frequent, routine insertions.

  • Reduced Complications Shown to reduce the likelihood of hematoma2 and eliminate infiltrations compared to a steel needle during testing of an artificial vessel.3

  • Automatic Safety Built-in, automatic safety mechanism designed to protect HD clinicians.

  • Patient Focused Designed to support the broadest range of patients while minimizing the risk of infiltration and maximizing comfort.

Learn More

LEARN MORE:

For Patients

Argyle™ Safety Fistula Cannula with Anti-Reflux Valve

Learn More

For Clinicians

Argyle™ Safety Fistula Cannula with Anti-Reflux Valve

Learn More

REFERENCES

1. Data on file, ArgyleTM Fistula Cannula Patient Survey, 2015

2. The End-Stage Renal Disease National Coordinating Center (ESRD NCC) Fistula First Catheter Last (FFCL) Workgroup Coalition. Fistula First Initiative: AVF–the first choice for hemodialysis. Available at: http://fistulafirst.org/. Accessed December 2, 2015.

3. Letachowicz K, Kusztal M, Golebiowski T, et al. Use of Plastic Needles for Early Arteriouvenous Fistula Cannulation. Blood Purification 2015;40:155-159.

4. The End-Stage Renal Disease National Coordinating Center (ESRD NCC) Fistula First Catheter Last (FFCL) Workgroup Coalition. Fistula First Initiative: AVF–the first choice for hemodialysis. Available at: http://fistulafirst.org/. Accessed December 2, 2015.

5. Lee T, Ul Haq N. New developments in our understanding of neointimal hyperplasia. Adv Chronic Kidney Dis. 2015;22:431-437